Data monitoring committees and selective outcome reportingBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d635 (Published 01 February 2011) Cite this as: BMJ 2011;342:d635
- Joseph Y Ting, clinical senior lecturer1
- 1Division of Anaesthesiology and Critical Care, University of Queensland, Brisbane, QLD 4067, Australia
Selective outcome reporting leading to biased treatment and adverse effect estimates could be discerned by independent re-evaluation of full outcome data that are made publicly available after publication of a clinical trial.1 However, it would be more efficient to use data monitoring committees to do this …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial